Anakinra—An Interleukin-1 Receptor Antagonist for COVID-19 : American Journal of Therapeutics

Secondary Logo

Journal Logo

Therapeutic Advance

Anakinra—An Interleukin-1 Receptor Antagonist for COVID-19

Nguyen, Timothy PharmD, MBA, BCPS, FASCP1; Dima, Lorena MD, PhD2,*; Willett, Kristine C. PharmD, FASHP3

Author Information
American Journal of Therapeutics 30(2):p e108-e116, March/April 2023. | DOI: 10.1097/MJT.0000000000001603

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid